Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFalpha) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathy.

Y Saeki; S Ohshima; T Mima; M Sasai; K Nishioka; M Shimizu; M Suemura; R McCloskey; T Kishimoto

doi:10.1080/030097498442433

Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFalpha) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathy.

Identifier:nobleid.org/w1/20260515/43DCB5DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/43DCB5DF.svg?ark=w1%2F20260515%2F43DCB5DF)](https://nobleid.org/work/w1/20260515/43DCB5DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Suboptimal clinical response to anti-tumor necrosis factor alpha (TNFalpha) antibody therapy in a patient with severe rheumatoid arthritis and lymphadenopathy.

Identifier:nobleid.org/w1/20260515/43DCB5DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/43DCB5DF.svg?ark=w1%2F20260515%2F43DCB5DF)](https://nobleid.org/work/w1/20260515/43DCB5DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work